The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy
Abstract
Background—: The long-term outcomes of transcatheter aortic valve replacement (TAVR) in inoperable patients with severe aortic stenosis remain unknown. Methods and Results—: In the Placement of Aortic Transcatheter Valves (PARTNER) study, 358 patients were randomly assigned to TAVR or standard therapy. We report the 3-year outcomes on these patients, and the pooled outcomes for all randomly assigned inoperable patients (n=449) in PARTNER, as well, including the randomized portion of the continued access study (n=91). The 3-year mortality rate in the TAVR and standard therapy groups was 54.1% and 80.9%, respectively ( P <0.001; hazard ratio, 0.53; 95% confidence interval, 0.41–0.68; P <0.001). In survivors, there was significant improvement in New York Heart Association functional class sustained at 3 years. The cumulative incidence of strokes at 3-year follow-up was 15.7% in TAVR patients versus 5.5% in patients undergoing standard therapy (hazard ratio, 2.81; 95% confidence interval, 1.26–6.26; P =0.012); however, the composite of death or strokes was significantly lower after TAVR versus standard therapy (57.4% versus 80.9%, P <0.001; hazard ratio, 0.60; 95% confidence interval, 0.46–0.77; P <0.001). Echocardiography showed a sustained increase in aortic valve area and decrease in transvalvular gradient after TAVR. Analysis of the 449 pooled randomly assigned patients (TAVR, n=220; standard therapy, n=229) demonstrated significant improvement in all-cause mortality and functional status during early and 3-year follow-up. The results of the pooled cohort were similar to the results obtained from the pivotal PARTNER trial. Conclusions—: TAVR resulted in better survival and functional status in inoperable patients with severe aortic stenosis with durable hemodynamic benefit on long-term follow-up. However, high residual mortality, even in successfully treated TAVR patients, highlights the need for more strategic patient selection. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00530894.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Leon, M. B., Smith, C. R., Mack, M., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008232 · Cited by 7,205
Self-citationTranscatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Smith, C. R., Leon, M. B., Mack, M. J., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103510 · Cited by 6,345
Self-citationDecision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?
Iung, B., Cachier, A., Baron, G., Messika-Zeitoun, D., Delahaye, F., Tornos, P., Gohlke-Bärwolf, C., Boersma, E., Ravaud, P., & Vahanian, A. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi471 · Cited by 1,108 · cited 1×
“However, a significant proportion of patients with severe symptomatic AS do not undergo aortic valve replacement because of a high estimated surgical mortality and morbidity.(3) Recently, transcatheter aortic valve replacement (TAVR) has emerged as an important treatment option for these highrisk patients.”
BackgroundMoat, N. E., Ludman, P., de Belder, M. A., Bridgewater, B., Cunningham, A. D., Young, C. P., Thomas, M., Kovac, J., Spyt, T., MacCarthy, P. A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.050 · Cited by 884
Green, P., Woglom, A. E., Genereux, P., Daneault, B., Paradis, J.-M., Schnell, S., Hawkey, M., Maurer, M. S., Kirtane, A. J., Kodali, S., et al. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.06.011 · Cited by 473
Self-citationTranscatheter aortic valve implantation: current and future approaches
Rodés-Cabau, J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.164 · Cited by 306 · cited 1×
“Cardiac comorbidities associated with poor outcome include low ejection fraction, pulmonary hypertension, severe mitral regurgitation, and coronary artery disease.(9,10,14,15)”
Background
Cited by
Mack, M. J., Leon, M. B., Smith, C. R., Miller, D. C., Moses, J. W., Tuzcu, E. M., Webb, J. G., Douglas, P. S., Anderson, W. N., Blackstone, E. H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60308-7 · Cited by 1,739
Self-citationKapadia, S. R., Leon, M. B., Makkar, R. R., Tuzcu, E. M., Svensson, L. G., Kodali, S., Webb, J. G., Mack, M. J., Douglas, P. S., Thourani, V. H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60290-2 · Cited by 867
Self-citationLudman, P. F., Moat, N., de Belder, M. A., Blackman, D. J., Duncan, A., Banya, W., MacCarthy, P. A., Cunningham, D., Wendler, O., Marlee, D., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013947 · Cited by 282
Metadata
- Authors
- Kapadia, S. R., Tuzcu, E. M., Makkar, R. R., Svensson, L. G., Agarwal, S., Kodali, S., Fontana, G. P., Webb, J. G., Mack, M., Thourani, V. H., Babaliaros, V. C., Herrmann, H. C., Szeto, W., Pichard, A. D., Williams, M. R., Anderson, W. N., Akin, J. J., Miller, D. C., Smith, C. R., & Leon, M. B.
- Venue
- Circulation
- Published
- 2014-10-21
- Volume
- 130
- Issue
- 17
- Pages
- 1483-1492
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2004907208
- Cited by
- 177
- References
- 6
- FWCI
- 20.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.